Related Experiment Video

Updated: Jun 28, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

Pharmacotherapy of yeast infections

Alicia Gómez-López1, Oscar Zaragoza, Juan Luis Rodríguez-Tudela

  • 1Instituto de Salud Carlos III, Servicio de Micología, Centro Nacional de Microbiología, Carretera Majadahonda-Pozuelo, Km2, Majadahonda 28220, Madrid, Spain.

Expert Opinion on Pharmacotherapy
|October 22, 2008
PubMed

Insights

Opportunistic yeast infections are increasing in immunocompromised patients. This review covers key yeast pathogens, their antifungal susceptibility, and treatment strategies using polyenes, azoles, and candins.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Rising incidence of immunocompromised individuals leads to increased opportunistic yeast infections.
  • Key clinical pathogens include Candida spp., Cryptococcus neoformans, Trichosporon spp., Rhodotorula spp., and Saccharomyces cerevisiae.
  • Management is complex, influenced by species and strain-specific antifungal susceptibility.

Purpose of the Study:

  • To review current knowledge on antifungal treatments for clinically relevant yeast infections.
  • To summarize in vitro antifungal susceptibility profiles of major yeast pathogens.
  • To provide insights into managing emerging yeast infections.

Main Methods:

  • Literature review of current scientific knowledge.
  • Analysis of antifungal susceptibility data for key yeast species.
  • Synthesis of information on treatment strategies and drug classes (polyenes, azoles, candins).

Main Results:

  • Candida and Cryptococcus remain primary concerns, with increasing infections from other yeasts.
  • Antifungal drug classes exhibit distinct activity spectra.
  • In vitro susceptibility data is crucial for guiding effective treatment decisions.

Conclusions:

  • Effective management of yeast infections requires understanding pathogen-specific susceptibility profiles.
  • The review highlights the importance of appropriate antifungal selection based on in vitro data.
  • Further research is needed to address evolving resistance patterns and novel therapeutic approaches.

More Related Videos

Quantifying the Antifungal Activity of Peptides Against Candida albicans06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms06:50

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms

Published on: September 16, 2022

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Yeast Signaling01:28

Yeast Signaling

Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...